PortfoliosLab logo

Addex Therapeutics Ltd (ADXN)

Equity · Currency in USD · Last updated Jan 21, 2023

Company Info

ISINUS00654J1079
CUSIP00654J107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.88
Year Range$0.55 - $5.95
EMA (50)$0.76
EMA (200)$2.09
Average Volume$190.01K
Market Capitalization$19.73M

ADXNShare Price Chart


Loading data...

ADXNPerformance

The chart shows the growth of $10,000 invested in Addex Therapeutics Ltd in Jan 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $605 for a total return of roughly -93.95%. All prices are adjusted for splits and dividends.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2023
-34.02%
1.31%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

ADXNCompare to other instruments

Search for stocks, ETFs, and funds to compare with ADXN

Addex Therapeutics Ltd

ADXNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD39.17%3.47%
1M44.21%3.95%
6M-54.57%-0.66%
1Y-84.98%-12.36%
5Y-64.27%2.02%
10Y-64.27%2.02%

ADXNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-8.90%-7.33%-4.33%1.97%-27.22%-69.50%0.70%-6.74%-25.93%6.25%-9.41%-18.18%
2021-19.74%-0.98%-1.41%-6.86%-4.40%2.24%3.04%-1.27%-7.35%-12.43%-11.15%-10.27%
2020-6.90%-16.30%-41.59%13.03%-2.41%19.74%6.63%60.95%-17.98%-10.11%-11.24%36.87%

ADXNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Addex Therapeutics Ltd Sharpe ratio is -0.55. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20AugustSeptemberOctoberNovemberDecember2023
-0.55
-0.51
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

ADXNDividend History


Addex Therapeutics Ltd doesn't pay dividends

ADXNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2023
-96.38%
-17.18%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)

ADXNWorst Drawdowns

The table below shows the maximum drawdowns of the Addex Therapeutics Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Addex Therapeutics Ltd is 97.71%, recorded on Dec 22, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.71%Dec 28, 2020502Dec 22, 2022
-57.31%Jan 31, 20207Mar 23, 202063Aug 7, 202070
-53.38%Aug 10, 202079Nov 30, 202018Dec 24, 202097

ADXNVolatility Chart

Current Addex Therapeutics Ltd volatility is 85.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%AugustSeptemberOctoberNovemberDecember2023
85.61%
16.43%
ADXN (Addex Therapeutics Ltd)
Benchmark (^GSPC)